BGNE, Target 69Flagpole breakout to a lower side. possibly to going to much earlier lower zone of 69
−3.477 BRL
−4.30 B BRL
11.98 B BRL
916.12 M
About BEIGENE, LTD.
Sector
CEO
John V. Oyler
Headquarters
George Town
Website
Founded
2010
ISIN
BRB1GNBDR002
FIGI
BBG00XX9JMM8
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where B1GN34 is featured.
